At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 604 enrolled
Drug / intervention
AN2690 Topical Solution, 5% +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Double-Blind, Vehicle-Controlled, Multi-Center Study to Evaluate the Efficacy and Safety of AN2690 Topical Solution, 5%, vs. Solution Vehicle in the Treatment of Onychomycosis of the Toenail in Adults
In Brief
A Phase 3 clinical trial evaluating AN2690 Topical Solution, 5% and Solution Vehicle for Onychomycosis of Toenails. Completed, enrolled 604 participants across 32 sites in 2 countries.
Detailed Summary
The purpose of this study is to determine whether AN2690 topical solution is a safe and effective treatment for onychomycosis of the toenail.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOnychomycosis of Toenails
CountriesCanada, United States
Collaborators--
Timeline
Phase 3CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartFeb 2011
First PostedFeb 2011
Primary CompletionDec 2012
Study CompletionFeb 2013
TodayJul 2026
First PostedFeb 23, 2011
Enrollment StartFeb 1, 2011
Primary CompletionDec 31, 2012
Study CompletionFeb 20, 2013
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 15.4 years ago
Interventions
AN2690 Topical Solution, 5%drug
AN2690 Topical Solution, 5%, applied once daily for 48 weeks
Solution Vehicledrug
AN2690 Topical Solution, Vehicle, applied once daily for 48 weeks